What is the latest market price of a box of Imatinib/Gleevec in 2025?

Imatinib/Gleevec (Imatinib) is a targeted therapy drug widely used to treat chronic myelogenous leukemia (CML) and some other tumors. Due to its remarkable therapeutic effects, imatinib is widely used worldwide. There are many manufacturers of imatinib drugs. Among them, there are some differences between the imported drugs of the original drug manufacturer Novartis and domestic generic drugs. These differences are mainly reflected in the production quality, price and patient experience of drug use.

From the perspective of drug quality control, the production process and quality control of imported imatinib are usually more stringent. As the original research company of imatinib, Novartis has many years of research and development experience and globally unified production standards. The stability, purity and consistency of the drug are high. In contrast, although domestically produced imatinib has undergone strict clinical verification and quality testing, due to differences in the production processes of different manufacturers, there may be certain differences in the stability or consistency of the efficacy of the drug.

In terms of efficacy, although the active ingredient of imported drugs and domestic drugs is the same, which is imatinib, due to individual differences and patients' different sensitivity to drugs, some patients may have different reactions to domestic drugs or imported drugs. Some patients have reported that imported drugs may be slightly better than domestic drugs in terms of tolerance or side effect control, but this does not mean that domestic drugs are less effective, but more a reflection of the need for individualized treatment.

From a price point of view, the price of imported imatinib is usually higher, mainly due to the research and development costs of the original drug, patent fees and other related expenses. Due to the relatively low production cost of domestic imatinib and the government’s policy support for generic drugs, the price of domestic imatinib is generally much lower than that of imported drugs. This has reduced the financial burden on many patients, especially for patients with chronic diseases who need long-term medication. The price difference has become an important factor in deciding to use domestic or imported drugs.

Reference materials:https://www.gleevec.com/